天天操天天擦,热re66久久精品国产99re,国产成在线观看免费视频

證據文獻

NO	論文	登載期刊	PM ID	全文鏈接	中文鏈接
1	輔助免疫細胞療法與全身系統性療法結合治療實體瘤的療效	Anticancer Research 42: 4179-4187　/ 2022	35896218	https://ar.iiarjournals.org/content/42/8/4179	http://www.gabrielden.com/laitian/results/22.html
2	食管癌對免疫細胞療法和低劑量納武單抗聯合治療有反應	Journal of Medical Case Reports 15, Article number: 191 / 2021	33827668	https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z	http://www.gabrielden.com/laitian/results/23.html
3	免疫細胞療法治療晚期/復發性乳腺癌的預后因素	Anticancer Research 41:4133-4141 / 2021	34281884	https://ar.iiarjournals.org/content/41/8/4133.long	http://www.gabrielden.com/laitian/results/1.html
4	過繼性T細胞免疫治療對晚期胰腺癌患者免疫學指標及預后的影響	CYTOTHERAPYFeb;23(2):137-145/2020	32907781	https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6	http://www.gabrielden.com/laitian/results/2.html
5	接受一線化療免疫治療的轉移性結直腸癌患者的免疫狀態變化	Anticancer Research 40:4763-4771 / 2020	32727803	https://ar.iiarjournals.org/content/40/8/4763.long	http://www.gabrielden.com/laitian/results/3.html
6	過繼免疫細胞治療子宮頸神經內分泌癌	Anticancer Research 40:4741-4748 / 2020	32727800	https://ar.iiarjournals.org/content/40/8/4763	http://www.gabrielden.com/laitian/results/4.html
7	免疫細胞治療子宮內膜癌和宮頸癌預后因素的回顧性研究	Anticancer Research 40:4729-4740 / 2020	32727799	https://ar.iiarjournals.org/content/40/8/4729.long	http://www.gabrielden.com/laitian/results/5.html
8	適應性免疫細胞治療對晚期胃癌患者免疫細胞譜的影響	Cancer Med 9(14):4907-4917 / 2020	32529780	https://ar.iiarjournals.org/content/40/8/4729.long	http://www.gabrielden.com/laitian/results/6.html
9	γδT細胞免疫治療實體瘤預后因素的研究	CYTOTHERAPY Jun;22(6):329-336 / 2020	32303429	https://pubmed.ncbi.nlm.nih.gov/32303429/	http://www.gabrielden.com/laitian/results/7.html
10	免疫細胞聯合一線化療治療結直腸癌的預后因素：一項回顧性研究	Anticancer Research 39: 4525-4532 / 2019	31366555	https://pubmed.ncbi.nlm.nih.gov/31366555/	http://www.gabrielden.com/laitian/results/8.html
11	免疫細胞治療胰腺癌患者的預后因素	Anticancer Research 38 (7) 4353-4360 / 2018	29970573	https://pubmed.ncbi.nlm.nih.gov/29970573/	http://www.gabrielden.com/laitian/results/9.html
12	腫瘤內注射唑來膦酸鹽沖擊樹突狀細胞、靜脈過繼活化T淋巴細胞和吉西他濱聯合綜合免疫治療不可切除的局部晚期胰腺癌的I/II期臨床研究	Oncotarget Dec5;9(2):2838-2847./2017	29416816	https://pubmed.ncbi.nlm.nih.gov/29416816/	http://www.gabrielden.com/laitian/results/10.html
13	全身靜脈過繼轉移自體淋巴因子激活的αβT細胞改善替莫唑胺誘導的膠質瘤患者淋巴細胞減少	Anticancer Research Jul;37(7):3921-3932./2017	28668896	https://pubmed.ncbi.nlm.nih.gov/28668896/	http://www.gabrielden.com/laitian/results/11.html
14	過繼免疫聯合化療治療IV期結直腸癌的臨床研究（COMVI研究）	Anticancer Research Jul;37(7):3941-3946. / 2017	28668898	https://pubmed.ncbi.nlm.nih.gov/28668898/	http://www.gabrielden.com/laitian/results/12.html
15	過繼免疫細胞療法治療晚期胃癌的回顧性研究	Anticancer Research Jul;37(7):3947-3954. / 2017	28668899	https://pubmed.ncbi.nlm.nih.gov/28668899/	http://www.gabrielden.com/laitian/results/13.html
16	mRNA-EP制備的腫瘤血管靶向CAR-T細胞用于臨床研究的免疫學質量和性能	Mol Ther Oncolytics.Nov 16;3:16024. / 2016	27909701	https://pubmed.ncbi.nlm.nih.gov/27909701/	http://www.gabrielden.com/laitian/results/14.html
17	活化αβT細胞過繼免疫化療治療IV期結直腸癌	Anticancer Research Jul;36(7):3741-6. / 2016	27354648	https://pubmed.ncbi.nlm.nih.gov/27354648/	http://www.gabrielden.com/laitian/results/15.html
18	WT1抗原在多種實體癌細胞中表達的免疫組織化學分析	Anticancer Research 36(7):3715-3724 / 2016	27354645	https://pubmed.ncbi.nlm.nih.gov/27354645/	http://www.gabrielden.com/laitian/results/16.html
19	自體免疫細胞治療改善不同類型晚期癌癥患者的免疫功能受損	Anticancer Research 36(7):3715-3724 / 2016	26168498	https://pubmed.ncbi.nlm.nih.gov/26168498/	http://www.gabrielden.com/laitian/results/17.html
20	免疫細胞治療在不同類型晚期癌癥患者中的前瞻性安全性評價	Anticancer Research 35(8):4535-4543 / 2015	25075106	https://pubmed.ncbi.nlm.nih.gov/25075106/	http://www.gabrielden.com/laitian/results/18.html
21	在晚期癌癥患者中評估細胞免疫狀態受損和失衡，并通過過繼性T細胞免疫治療恢復T細胞免疫狀態	International Immunopharmacology18(1):90-97. / 2014	24269583	https://pubmed.ncbi.nlm.nih.gov/24269583/	http://www.gabrielden.com/laitian/results/19.html
22	封閉流式電穿孔系統治療實體瘤的自體腫瘤溶解物樹突狀細胞疫苗免疫治療	Anticancer Research 33(7):2971-6. / 2013	23780988	https://pubmed.ncbi.nlm.nih.gov/23780988/	http://www.gabrielden.com/laitian/results/20.html
23	晚期肺癌過繼性活化T淋巴細胞免疫治療中觀察到的生存期延長：一項多中心歷史性隊列研究的結果	Cancer Immunology, Immunotherapy 61:1781-1790. / 2012	22422103	https://pubmed.ncbi.nlm.nih.gov/22422103/	http://www.gabrielden.com/laitian/results/21.html

亚洲国产精品电影_久久成人人人人精品欧_av一区二区不卡_欧美尿孔扩张虐视频_亚洲日本一区二区三区在线观看_日韩中文视频免费在线观看_91色porny蝌蚪_天堂久久av_欧美狂欢多p性派对_日韩精品资源二区在线

證據文獻